Octozi pricing
No pricing is published, but the value case is quantified against a baseline sponsors can cost themselves: an economic analysis of a representative Phase III oncology trial estimated savings exceeding $5 million per study, driven primarily by earlier database lock and compressed timelines. Delayed database lock has a known cost to any sponsor, so that comparison can be modeled rather than left as an abstract efficiency claim. Two caveats.
How Octozi pricing works
- Pricing model
- Undisclosed. Sold to pharmaceutical sponsors, biotech, medtech, and contract research organizations; no rates published.
- Implementation
- Not disclosed. Designed to integrate with existing clinical systems rather than requiring migration, with seed funding earmarked to deepen those integrations.
- Business associate agreement
- Not disclosed. Customers are pharmaceutical sponsors and CROs rather than providers, so contracting runs through sponsor data agreements rather than HIPAA business associate terms.
The figure is vendor generated and models a representative rather than an actual trial, and the supporting controlled study covered 10 medical reviewers. Vendor durability is the other consideration: this is a seed stage company that raised $3 million in July 2026, competing in a function currently served by established contract research organizations, and it publishes no SOC 2 or equivalent attestation, which sponsors will likely require.
Octozi pricing against its alternatives
Published prices for Octozi and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- OOctoziNo published price
- SSaamaNo published price
- MMedidataNo published price
- QQuantHealthEnterprise engagement; terms not published
- CCluePointsNo published price
- VVeeva SystemsNo published price
- PParadigm HealthNo published price
Octozi pricing, answered
How much does Octozi cost?
Octozi does not publish a price. Delayed database lock has a known cost to any sponsor, so that comparison can be modeled rather than left as an abstract efficiency claim. Two caveats.
Does Octozi charge an implementation fee?
Not disclosed. Designed to integrate with existing clinical systems rather than requiring migration, with seed funding earmarked to deepen those integrations.
Does Octozi offer a business associate agreement?
Not disclosed. Customers are pharmaceutical sponsors and CROs rather than providers, so contracting runs through sponsor data agreements rather than HIPAA business associate terms.